Michael Sumner
Chief Tech/Sci/R&D Officer at INOVIO PHARMACEUTICALS, INC.
Net worth: 40 488 $ as of 2024-03-30
Network origin in Michael Sumner first degree
| Entity | Entity type | Industry | |
|---|---|---|---|
The Royal College of Physicians
118
| College/University | Other Consumer Services | 118 |
28
| Public Company | Pharmaceuticals: Major | 28 |
| Public Company | Pharmaceuticals: Major | 23 |
Chart of Companies connected to the second degree
Multi-company connection
Companies connected to Michael Sumner via their personal network
| Company | Sector | Related people | Main position |
|---|---|---|---|
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Sales & Marketing | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| JUNIPER PHARMACEUTICALS INC | Pharmaceuticals: Major | Director/Board Member Chief Executive Officer | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| ELI LILLY AND COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| MERCK & CO., INC. | Pharmaceuticals: Major | Corporate Officer/Principal Human Resources Officer Corporate Officer/Principal | |
| PFIZER, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| NPS PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Director/Board Member General Counsel | |
CuraGen Corp.
 CuraGen Corp. Pharmaceuticals: MajorHealth Technology CuraGen Corp. develops protein, antibody and small molecule pharmaceutical products. The firm focuses on the development of CR011-vcMMAE, a Phase II clinical trial drug for the treatment of patients with metastatic melanoma and breast cancer. The company was founded in 1991 and is headquartered in Branford, CT. | Pharmaceuticals: Major | Chief Executive Officer Director/Board Member | |
| ICON PUBLIC LIMITED COMPANY | Miscellaneous Commercial Services | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | |
Phoqus Pharmaceuticals Plc
 Phoqus Pharmaceuticals Plc Pharmaceuticals: MajorHealth Technology Phoqus Pharmaceuticals Plc develops pharmaceutical products. It's product Chronocort that helps to treat the patients with cortisol deficiency such as congenital adrenal hyperplasia and Addison's diseases. The company was founded in 1998 and is located in West Malling, UK. | Pharmaceuticals: Major | Chief Executive Officer Chief Executive Officer | |
| GSK PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Powderject Pharmaceuticals Plc
 Powderject Pharmaceuticals Plc Medical SpecialtiesHealth Technology Powderject Pharmaceuticals Plc develops pharmaceutical products. It offers researching, developing, manufacturing and marketing for existing and next generation vaccines. The company was founded in 1993 and is located in Oxford, UK | Medical Specialties | Director/Board Member Corporate Officer/Principal | |
| OXFORD BIOMEDICA PLC | Biotechnology | President Corporate Officer/Principal Corporate Officer/Principal | |
| National University of Singapore | College/University | Graduate Degree Undergraduate Degree Doctorate Degree Corporate Officer/Principal Doctorate Degree Doctorate Degree | |
| University of Oxford | College/University | Undergraduate Degree Corporate Officer/Principal Graduate Degree Corporate Officer/Principal Doctorate Degree | |
| Imperial College London | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree | |
Hoffmann-La Roche, Inc.
 Hoffmann-La Roche, Inc. BiotechnologyHealth Technology Hoffmann-La Roche, Inc. manufactures pharmaceutical drugs. Its products include influenza fighter Tamiflu, controversial acne medication Accutane, HIV inhibitor Fuzeon, obesity drug Xenical, and hepatitis C therapy Pegasys. The company was founded in 1896 Roche and is headquartered in Nutley, NJ. | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| The University of Manchester | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
| University of Glasgow | College/University | Undergraduate Degree Doctorate Degree Undergraduate Degree Doctorate Degree | |
| University of Cambridge | College/University | Doctorate Degree Masters Business Admin Doctorate Degree Undergraduate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of Malaya | College/University | Undergraduate Degree Undergraduate Degree | |
| University of Hong Kong | College/University | Doctorate Degree Doctorate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree Graduate Degree | |
| University of London | College/University | Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Doctorate Degree Undergraduate Degree | |
| The University of Edinburgh | College/University | Undergraduate Degree Director/Board Member Undergraduate Degree Doctorate Degree Doctorate Degree | |
| University of Bristol | College/University | Doctorate Degree Undergraduate Degree | |
| University College London | College/University | Undergraduate Degree Undergraduate Degree Undergraduate Degree Undergraduate Degree | |
Nabriva Therapeutics GmbH
 Nabriva Therapeutics GmbH Pharmaceuticals: MajorHealth Technology Nabriva Therapeutics GmbH is a clinical-stage biopharmaceutical company, which engages in the research and development of novel anti-infective agents to treat serious infections. It focuses on the pleuromutilin class of antibiotics. The company was founded by Rodger Novak in October 2005 and is headquartered in Vienna, Austria. | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| The Chinese University of Hong Kong | College/University | Graduate Degree Undergraduate Degree | |
American Society of Clinical Oncology, Inc.
 American Society of Clinical Oncology, Inc. Medical/Nursing ServicesHealth Services The American Society of Clinical Oncology is a non-profit organization founded in 1964 with the overarching goals of improving cancer care and prevention. More than 27,000 oncology practitioners belong to ASCO, representing all oncology disciplines and subspecialties. Members include physicians and health-care professionals in all levels of the practice of oncology. American Society of Clinical Oncology is the world’s leading professional organization representing physicians who treat people with cancer. ASCO’s members set the standard for patient care worldwide and lead the way in carrying out clinical research aimed at improving the prevention, diagnosis, and treatment of cancer. ASCO's efforts are also directed toward advocating for policies that provide access to high-quality care for all patients with cancer and at supporting the increased funding for clinical and translational research. | Medical/Nursing Services | Corporate Officer/Principal Corporate Officer/Principal | |
| Faculty of Pharmaceutical Medicine | Corporate Officer/Principal Corporate Officer/Principal Director/Board Member Corporate Officer/Principal Corporate Officer/Principal | ||
Takeda Pharmaceuticals U.S.A., Inc.
 Takeda Pharmaceuticals U.S.A., Inc. Pharmaceuticals: MajorHealth Technology Takeda Pharmaceuticals U.S.A., Inc. develops and markets pharmaceutical products. It offers metabolic and cardiovascular, respiratory and immunology, central nervous system, oncology, and general medicine products. The company was founded in 1998 and is headquartered in Deerfield, IL. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
Merck Research Laboratories Massachusetts LLC
 Merck Research Laboratories Massachusetts LLC Pharmaceuticals: MajorHealth Technology Part of Merck & Co., Inc., Merck Research Laboratories Massachusetts LLC is a pharmaceutical company that provides free medicines and adult vaccines to qualified patients through their Merck Patient Assistance Program. The private company is based in Boston, MA and is a part of Merck & Co., Inc. and its affiliates. The company also offers information about insurance coverage and financial assistance options for eligible patients. The company conducts clinical trials and provides medical information covering thousands of topics in all fields of medicine through their Merck Manuals. Additionally, they report on their commitment to operating responsibly to benefit society through their corporate responsibility program, which includes their environmental, social, and governance (ESG) report. Merck for Mothers is an initiative to create a world where no woman has to die giving life. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member Corporate Officer/Principal | |
| Hoechst Marion Roussel, Inc. | Chief Tech/Sci/R&D Officer Corporate Officer/Principal | ||
Spark Therapeutics Ireland Ltd.
 Spark Therapeutics Ireland Ltd. Pharmaceuticals: MajorHealth Technology Spark Therapeutics Ireland Ltd. develops new gene medicines to treat autosomal dominant genetic diseases. Its product RhoNova, is designed for the treatment of patients with rhodopsin linked autosomal dominant retinitis pigmentosa, a debilitating, progressive form of inherited blindness resulting from a diverse array of mutations in the RHO gene. The company was founded by Jane G. Farrar, Paul Kenna, and Gearóid Tuohy and is headquartered in Dublin, Ireland. | Pharmaceuticals: Major | Director/Board Member Founder | |
| Harvard Medical School | College/University | Director/Board Member Corporate Officer/Principal | |
GlaxoSmithKline LLC
 GlaxoSmithKline LLC Pharmaceuticals: MajorHealth Technology GlaxoSmithKline LLC engages in discovering, developing, and delivering medicines, vaccines, and other healthcare products. It offers prescription medicines that treat various diseases, including cancer, HIV/AIDS, depression, diabetes, high blood pressure, herpes, asthma, migraine, and heart diseases, as well as stomach and skin problems, infections, and flu. It also provides vaccines for children and adults; and over-the-counter products. The company was founded in 1929 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Singapore General Hospital Pte Ltd.
 Singapore General Hospital Pte Ltd. Medical/Nursing ServicesHealth Services Part of MOH Holdings Pte Ltd., Singapore General Hospital Pte Ltd. is a general hospital established in 1821 and is the largest tertiary hospital in Singapore. The private company is based in Singapore, Singapore. As an academic medical centre, it takes pride in training healthcare professionals and conducting cutting edge research to meet evolving needs of the nation as well as the region. SGH is committed to providing the most comprehensive patient-centered care with over 50 clinical specialties on its campus. | Medical/Nursing Services | Director/Board Member Corporate Officer/Principal | |
Zeneca Pharmaceuticals
 Zeneca Pharmaceuticals Pharmaceuticals: MajorHealth Technology Zeneca Pharmaceuticals manufactures medicines. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Tech/Sci/R&D Officer | |
| The Royal College of Paediatrics & Child Health | College/University | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
TranScrip Partners LLP
 TranScrip Partners LLP Pharmaceuticals: MajorHealth Technology TranScrip Partners LLP is a consultancy provider for biotech and pharmaceutical companies. TranScrip Partners was founded in 2008 and is based in Wokingham, UK. The British company offers development and commercialization services to its clients. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| PUMA BIOTECHNOLOGY, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member | |
Cardiorentis AG
 Cardiorentis AG Pharmaceuticals: MajorHealth Technology Cardiorentis AG operates as a biopharmaceutical company. It offers novel therapies to the treatment of heart failure and related cardiovascular diseases. The company was founded in 2010 and is headquartered in Zug, Switzerland. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| NABRIVA THERAPEUTICS PLC | Pharmaceuticals: Major | Chief Executive Officer General Counsel | |
| SPRINGWORKS THERAPEUTICS, INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ENGENE HOLDINGS INC. | Biotechnology | Director/Board Member Chief Tech/Sci/R&D Officer | |
| ALLENA PHARMACEUTICALS, INC. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Director/Board Member |
Statistics
International
| United States | 22 |
| United Kingdom | 18 |
| Ireland | 4 |
| Singapore | 3 |
| Hong Kong | 3 |
Sectoral
| Health Technology | 31 |
| Consumer Services | 16 |
| Health Services | 3 |
| Commercial Services | 2 |
Operational
| Director/Board Member | 574 |
| Corporate Officer/Principal | 326 |
| Independent Dir/Board Member | 115 |
| Chief Tech/Sci/R&D Officer | 106 |
| Chairman | 70 |
Most connected contacts
| Insiders | |
|---|---|
| Cheok Peng Lim | 128 |
| Tong Choon Cheo | 44 |
| Frank Armstrong | 41 |
| James Noble | 39 |
| Jay Shepard | 30 |
| Freda Lewis-Hall | 29 |
| Ik King Tiong | 29 |
| Peng Tiam Ang | 26 |
| Paul Blake | 23 |
| Preetinder Singh Joshi | 23 |
| Christine Rankin | 23 |
| David J. Clark | 21 |
| Warren Cooper | 21 |
| Lota Zoth | 20 |
| Wendy Yarno | 19 |
- Stock Market
- Insiders
- Michael Sumner
- Company connections
